BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7361243)

  • 21. Further evidence of the validity of risk group definition in differentiated thyroid carcinoma.
    Cady B; Rossi R; Silverman M; Wool M
    Surgery; 1985 Dec; 98(6):1171-8. PubMed ID: 4071392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High recurrent rate of multicentric papillary thyroid carcinoma.
    Lin JD; Chao TC; Hsueh C; Kuo SF
    Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors in patients with differentiated thyroid carcinoma.
    Steinmüller T; Klupp J; Rayes N; Ulrich F; Jonas S; Gräf KJ; Neuhaus P
    Eur J Surg; 2000 Jan; 166(1):29-33. PubMed ID: 10688213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Thyroid carcinoma: evaluation of prognostic factors].
    d'Annibale M; Piovanello P; Appetecchia M; Grauso F; Bruno PL; Perri P; Piarulli L
    Chir Ital; 1999; 51(1):59-64. PubMed ID: 10514918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical treatment of papillary thyroid carcinoma: uni- and multivariate analysis of prognostic factors (TNM staging system included).
    Pelizzo MR; Toniato A; Grigoletto R
    J Exp Clin Cancer Res; 1997 Sep; 16(3):261-5. PubMed ID: 9387899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term survival rates in young patients with thyroid carcinoma.
    Kowalski LP; Gonçalves Filho J; Pinto CA; Carvalho AL; de Camargo B
    Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):746-9. PubMed ID: 12874076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Differentiated thyroid carcinoma: prognostic factors].
    Györy F; Lukács G; Nagy EV; Juhász F; Mezösi E; Szakáll S; Máth J; Balázs G
    Magy Seb; 2001 Apr; 54(2):69-74. PubMed ID: 11339092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Significance of lymph node metastases of differentiated thyroid gland carcinomas and C-cell carcinomas for prognosis--a meta-analysis].
    Witte J; Schlotmann U; Simon D; Dotzenrath C; Ohmann C; Goretzki PE
    Zentralbl Chir; 1997; 122(4):259-65. PubMed ID: 9221636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [On the treatment of carcinoma of the thyroid (author's transl)].
    Biersack HJ; Vogt M; Helpap B; Janson R; Rau W; Winkler C
    Dtsch Med Wochenschr; 1981 Mar; 106(13):390-5. PubMed ID: 7215162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term results in elderly patients with differentiated thyroid carcinoma.
    Vini L; Hyer SL; Marshall J; A'Hern R; Harmer C
    Cancer; 2003 Jun; 97(11):2736-42. PubMed ID: 12767085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management and outcome of recurrent well-differentiated thyroid carcinoma.
    Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multivariate study of prognostic factors for differentiated thyroid carcinoma: the significance of histologic subtype.
    Noguchi M; Mizukami Y; Michigishi T; Koyasaki N; Ohta N; Miyazaki I
    Int Surg; 1993; 78(1):10-5. PubMed ID: 8473075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognostic index in cancer of the thyroid gland].
    Lukomskiĭ GI; Ivanova NA; Kabanova GM; Seredin VP
    Vestn Khir Im I I Grek; 1988 Feb; 140(2):3-6. PubMed ID: 3388705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microvessel count: an indicator of poor outcome in medullary thyroid carcinoma but not in other types of thyroid carcinoma.
    Fontanini G; Vignati S; Pacini F; Pollina L; Basolo F
    Mod Pathol; 1996 Jun; 9(6):636-41. PubMed ID: 8782200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic scoring systems in differentiated thyroid carcinoma: which is the best?
    Kingma G; van den Bergen HA; de Vries JE
    Neth J Surg; 1991 Jun; 43(3):63-6. PubMed ID: 1922882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
    Haq M; Harmer C
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapeutic results of malignant goiter 1960-1980. Significance of percutaneous radiotherapy in well differentiated carcinomas].
    Leisner B; Degelmann G; Dirr W; Kanitz W; Büll U; Langhammer H; Lissner J; Pabst HW
    Dtsch Med Wochenschr; 1982 Nov; 107(45):1702-7. PubMed ID: 7140548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Differentiated cancer of the thyroid: prognostic aspects].
    Veroux P; Fazzi C; Cavallaro A; Veroux M; Cannizzaro MA
    Chir Ital; 1997; 49(1-2):37-41. PubMed ID: 12743874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of postoperative serum thyroglobulin levels in patients with papillary and follicular thyroid carcinomas.
    Lin JD; Huang MJ; Hsu BR; Chao TC; Hsueh C; Liu FH; Liou MJ; Weng HF
    J Surg Oncol; 2002 May; 80(1):45-51. PubMed ID: 11967907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
    Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
    Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.